Plasma cell leukemia is a rare disease entity where the number of clonal plasma cells in the peripheral blood exceeds 2X109/l or 20% of the total leukocyte count. This plasma cell leukemia can be primary which is arising denovo or secondary as in the course of plasma cell myeloma. A 48 years old male patient came to the emergency outpatient department with complaints of acute renal failure without any prior history of diabetes or hypertension. On examination patient also had hepatosplenomegaly. Peripheral smear showed 56% plasmacytoid cells. Bone marrow aspirate and biopsy revealed a hyper cellular marrow. Marrow showed chiefly plasmablasts (32%) with plenty of abnormal plamacytoid cells (21%). Other marrow elements were grossly reduced. This case is presented because of its rarity, presenting at a younger age, primary type of plasma cell leukemia, presence of organomegaly and unique morphology of the cells in the blood and bone marrow.
Plasma cell leukemia (PCL) is a rare disorder. Patients may either present de novo (primary PCL), or PCL may occur during the course of multiple myeloma (secondary PCL). [
A 48 yrs old male patient came in emergency OPD with the chief complain of acute renal failure with a serum urea 194.6 mg/dl and serum creatinine of 8.5 mg/ . His previous medical and family histories were unremarkable. On examination there was moderate hepato-splenomegaly and the blood sample was send to pathology department for complete blood count and general blood picture. His results were as follows -Hb 4.5 g/dl, total leucocyte count 17000 cells/ cu mm with a differential of polymorphs 42 %, monocytes 01%, eosinophil 01% and
plasma cells with plasmacytoid lymphocytes 56% . Platelets were grossly reduced with a count of 50,000/ cu mm. On bone marrow examination, aspirate showed a hypercellular marrow with predominant plamacytoid cell population hyperplasia consisting chiefly of plasmablasts (32%) with plenty of abnormal plamacytoid cells (21%).
All other series like erythroid , myeloid and megakaryocyte were grossly reduced by smear.
With this haematological findings, diagnosis of Plasma cell leukemia was made and patient further evaluated for S. Ca++, S. LDH and
Plasma cell leukemia is important to recognize because of its rarity of occurrence and unusual presentation. There are two types of PCL: Primary PCL – diagnosed in patients with no history of myeloma, Secondary PCL – occurs after a previous myeloma diagnosis and arises when myeloma progresses to PCL. The likelihood of myeloma patients developing secondary PCL is very low (about 0.5 - 1%). Secondary PCL is thought to be caused by an accumulation of specific genetic changes that occur within myeloma cells as the myeloma progresses in certain patients. It is estimated that 1 per million of the general population are diagnosed with primary PCL each year, while approximately 1 in 100 myeloma patients will go on to develop secondary PCL.
This case is presented because of its rarity, presenting at a younger age, primary type of plasma cell leukemia, presence of organomegaly, morphology of the cells in the blood and bone marrow and poor prognosis of the patient.
A case of 51 year old male patient with history of fever and altered sensorium, with peripheral blood plasma cells of 24% was reported by Abid Jameel.[
Primary plasma cell leukemia becomes important because of its rarity of presentation, clinical presentation, morphological difference from myeloma cells, and expression of immune markers and survival of the patient.
We have studied and reported this case of primary plasma cell leukemia, because age of presentation of patient was only 48yrs, quiet younger then what is the documented age i.e. 55yrs, presence of organomegaly in the form of hepatosplenomegaly, abscence of lytic lesions of bone and most importantly very poor prognosis of the disease.
Plasma cell leukaemia [Internet]. Edinburgh: Myeloma UK; Aug 2008[ updated feb 2017]. Available from:https://www.myeloma.org.uk/Myeloma-UK-Plasma-Cell-Leukaemia-Infosheet.pdf
Noel P, Kyle RA. Plasma cell leukemia: an evaluation of response to therapy. Am J Med 1987;83: 1062–1068.
McKenna RW, Kyle RA, Kuehl WM, Grogan TM, Harris NL, Coupland RW (2008). Plasma cell neoplasms. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Lyon. 200-213.
Naseem S, Kaur S, Gupta R, Kashyap R, Nitayand S (2012). Plasma cell leukaemia; Case series from a tertiary centre with review of literature. Indian Journal of Hamatology and Blood Transfusion 28(1):10-14.
Gertz MA, Buadi FK. (2010). Plasma cell leukaemia. Haematologica 95(5) 705-707.